Interventional/Surgery news, opinions and education

The selected article could not be found. Try again later or contact administrator.

Interventional/Surgery

Some valve patients are too sick for TAVI or surgery

1 COMMENT - May 2, 2012 17:40 EDT

Most of the discussion of PARTNER trial and early rollout of transcatheter valves focused on differentiating TAVI candidates from patients better suited to surgical valve replacement. While experts continue to be alarmed by the number of relatively low-risk patients getting TAVI in some countries, they're also drawing attention to the number of TAVI procedures in patients who are too sick to benefit from any valve replacement.

San Francisco, CA - Too many patients who cannot benefit from aortic-valve replacement are being treated with transcatheter valve implants, according to Dr Craig Miller (Stanford University, CA), one of the surgeon investigators of the pivotal PARTNER trial.

"When it was new and we were experimenting, then you can do [transcatheter aortic-valve implantation (TAVI) in] anybody and you figure out if it's going to work and how to do it, but we know from all of these registries and the PARTNER trial, both cohort A and cohort B, that we're overextending the envelope on the older and sicker 'cohort C' side," Miller told heartwire. "These are patients who are so sick and so old that they're not going to benefit."
Read full article »

Interventional/Surgery

Simple risk score aids carotid-stenting decisions

May 17, 2012 09:15 EDT

Interventional/Surgery

TAVI numbers rise in Europe as reimbursement, expertise expands

May 17, 2012 09:00 EDT

Features

So long, Plavix, what a ride! Clopidogrel patent expires

May 16, 2012 14:45 EDT

Interventional/Surgery

COMFORTABLE-AMI: Bioerodable polymer DES trumps bare metal in STEMI

May 16, 2012 10:50 EDT

Interventional/Surgery

COMPARE II: Nobori biolimus stent matches everolimus stents in all-comers

May 16, 2012 10:15 EDT

Heart failure

TAVI to treat surgical valve failure shows potential, with caveats

May 15, 2012 13:00 EDT

From the blogsView all »

Cutting-edge dialogues with
Drs Tim Gardner and Mat Williams

Can the "heart team" work?

Nov 23, 2011 16:30 EST

Editorial programs

Debate and dialogue between top cardiovascular specialists, produced by
theheart.org's editorial team

View all »

Starting with ASCERT, a look at observational studies

May 8, 2012 08:53 EDT

Are appropriate-use criteria for coronary revascularization advancing patient care?

Apr 30, 2012 08:20 EDT

The creative destruction of medicine with Dr Eric Topol

Apr 24, 2012 13:30 EDT

View all »Collections

heartwire collections groups our most compelling cardiology news coverage and editorial content by popular themes. Find everything on a single topic, in one place, with one click.

Erectile dysfunction and CHD

Years ago, Viagra made the unexpected transition from hypertension and angina drug...

Antiplatelet up-and-comers

The quest for ever-more effective drugs to decrease platelet aggregation and reduce the...

The Myxo ring mix-up

In 2008, a heartwire investigation reported on a mitral annuloplasty ring, invented by...

Clopidogrel and PPIs

Proton-pump inhibitors have been prescribed to reduce the gastrointestinal risks of...

Pondering prasugrel

The much-anticipated antiplatelet agent gained FDA approval on the basis of the pivotal...

What's New